{"abstract":"The Food and Drug Administration (FDA or Agency) is announcing a public meeting and an opportunity for public comment on Patient- Focused Drug Development for idiopathic pulmonary fibrosis. Patient- Focused Drug Development is part of FDA's performance commitments made as part of the fifth authorization of the Prescription Drug User Fee Act (PDUFA V). The public meeting is intended to allow FDA to obtain patient perspectives on the impact of idiopathic pulmonary fibrosis on daily life as well as patient views on treatment approaches for idiopathic pulmonary fibrosis.","action":"Notice of public meeting; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2014/07/08/2014-15871.html","cfr_references":[],"citation":"79 FR 38539","comment_url":null,"comments_close_on":"2014-11-26","correction_of":null,"corrections":[],"dates":"The public meeting will be held on September 26, 2014, from 1 p.m. to 5 p.m. Registration to attend the meeting must be received by September 10, 2014 (see SUPPLEMENTARY INFORMATION for instructions). Submit electronic or written comments by November 26, 2014.","disposition_notes":null,"docket_ids":["Docket No. FDA-N-2014-0865"],"dockets":[{"supporting_documents":[],"agency_name":null,"documents":[{"comment_count":36,"comment_start_date":"2014-07-08","updated_at":"2023-03-01T13:13:09.018-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2014-N-0865-0001","allow_late_comments":null,"id":"FDA-2014-N-0865-0001","comment_end_date":"2014-11-27","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-2014-N-0865","title":"Public Meeting on Patient-Focused Drug Development for Idiopathic Pulmonary Fibrosis"}],"document_number":"2014-15871","effective_on":null,"end_page":38541,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2014/07/08/2014-15871.xml","html_url":"https://www.federalregister.gov/documents/2014/07/08/2014-15871/patient-focused-drug-development-for-idiopathic-pulmonary-fibrosis-public-meeting-request-for","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2014-15871?publication_date=2014-07-08","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2014-07-08/2014-15871/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":889,"last_updated":"2026-07-28 06:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2014-07-08/pdf/2014-15871.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2014-15871.pdf?1404737380","publication_date":"2014-07-08","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2014/07/08/2014-15871.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":36,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2014-N-0865","supporting_documents_count":0,"docket_id":"FDA-2014-N-0865","document_id":"FDA-2014-N-0865-0001","regulation_id_number":null,"title":"Public Meeting on Patient-Focused Drug Development for Idiopathic Pulmonary Fibrosis","checked_regulationsdotgov_at":"2023-03-01T18:13:08Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":38539,"subtype":null,"title":"Patient-Focused Drug Development for Idiopathic Pulmonary Fibrosis; Public Meeting; Request for Comments","toc_doc":"Patient-Focused Drug Development for Idiopathic Pulmonary Fibrosis","toc_subject":"Meetings:","topics":[],"type":"Notice","volume":79}